Literature DB >> 18469851

Mechanism of G1-like arrest by low concentrations of paclitaxel: next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosis.

Z N Demidenko1, S Kalurupalle, C Hanko, C-u Lim, E Broude, M V Blagosklonny.   

Abstract

Paclitaxel (PTX) and other microtubule inhibitors cause mitotic arrest. However, low concentrations of PTX (low PTX) paradoxically cause G1 arrest (without mitotic arrest). Here, we demonstrated that unexpectedly, low PTX did not cause G1 arrest in the first cell cycle and did not prevent cells from passing through S phase and entering mitosis. Mitosis was prolonged but cells still divided, producing either two or three cells (tripolar mitosis), thus explaining a sub G1 peak caused by low PTX. Importantly, sub G1 cells were viable and non-apoptotic. Some cells fused back and then progressed to mitosis, frequently producing three cells again before becoming arrested in the next cell-cycle interphase. Thus, low PTX caused postmitotic arrest in second and even the third cell cycles. By increasing concentration of PTX, tripolar mitosis was transformed to mitotic slippage, thus eliminating a sub G1 peak. Time-lapse microscopy revealed that prolonged mitosis ensured a p53-dependent postmitotic arrest. We conclude that PTX directly affects cells only in mitosis and the duration of mitosis determines cell fate, including p53-dependent G1-like arrest.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18469851     DOI: 10.1038/onc.2008.82

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  43 in total

1.  Action of SN 28049, a new DNA binding topoisomerase II-directed antitumour drug: comparison with doxorubicin and etoposide.

Authors:  Catherine J Drummond; Graeme J Finlay; Laura Broome; Elaine S Marshall; Emma Richardson; Bruce C Baguley
Journal:  Invest New Drugs       Date:  2010-06-22       Impact factor: 3.850

2.  Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle.

Authors:  Miles A Miller; Suresh Gadde; Christina Pfirschke; Camilla Engblom; Melissa M Sprachman; Rainer H Kohler; Katherine S Yang; Ashley M Laughney; Gregory Wojtkiewicz; Nazila Kamaly; Sushma Bhonagiri; Mikael J Pittet; Omid C Farokhzad; Ralph Weissleder
Journal:  Sci Transl Med       Date:  2015-11-18       Impact factor: 17.956

3.  Genes potentially associated with resistance of lung cancer cells to paclitaxel.

Authors:  K N Kashkin; E A Musatkina; A V Komelkov; D A Sakharov; E V Trushkin; E A Tonevitsky; T V Vinogradova; E P Kopantzev; M V Zinovyeva; O V Kovaleva; K A Arkhipova; I B Zborovskaya; A G Tonevitsky; E D Sverdlov
Journal:  Dokl Biochem Biophys       Date:  2011-05-18       Impact factor: 0.788

4.  Drug-targeting in combined cancer chemotherapy: tumor growth inhibition in mice by association of paclitaxel and etoposide with a cholesterol-rich nanoemulsion.

Authors:  Iara F Kretzer; Durvanei A Maria; Raul C Maranhão
Journal:  Cell Oncol (Dordr)       Date:  2012-10-03       Impact factor: 6.730

5.  The microtubule stabilizer patupilone (epothilone B) is a potent radiosensitizer in medulloblastoma cells.

Authors:  Christoph Oehler; André O von Bueren; Polina Furmanova; Angela Broggini-Tenzer; Katrin Orlowski; Stefan Rutkowski; Karl Frei; Michael A Grotzer; Martin Pruschy
Journal:  Neuro Oncol       Date:  2011-07-09       Impact factor: 12.300

6.  Tetraploid cells produced by absence of substrate adhesion during cytokinesis are limited in their proliferation and enter senescence after DNA replication.

Authors:  Marco De Santis Puzzonia; Laetitia Gonzalez; Sonia Ascenzi; Enrico Cundari; Francesca Degrassi
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

7.  1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) Alters Cell Cycle Progression in Human Neuroblastoma Cell Lines.

Authors:  Rakesh Kumar Sharma; Eduardo Candelario-Jalil; Doris Feineis; Gerhard Bringmann; Bernd L Fiebich; Ravi Shankar Akundi
Journal:  Neurotox Res       Date:  2017-07-18       Impact factor: 3.911

8.  Taxane-mediated radiosensitization derives from chromosomal missegregation on tripolar mitotic spindles orchestrated by AURKA and TPX2.

Authors:  M Orth; K Unger; U Schoetz; C Belka; K Lauber
Journal:  Oncogene       Date:  2017-09-04       Impact factor: 9.867

9.  Protection of p53 wild type cells from taxol by nutlin-3 in the combined lung cancer treatment.

Authors:  Sergey V Tokalov; Nasreddin D Abolmaali
Journal:  BMC Cancer       Date:  2010-02-23       Impact factor: 4.430

Review 10.  Nanoparticle drug-delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle.

Authors:  Aaron H Colby; Nicholas H Oberlies; Cedric J Pearce; Victoria L M Herrera; Yolonda L Colson; Mark W Grinstaff
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.